National consensus on management patients with endometriosis

Abstract

Condition tags

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (24)

• A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
• A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study via openalex
• Consensus on current management of endometriosis via openalex
• Dienogest: an oral progestogen for the treatment of endometriosis via openalex
• Dienogest in long-term treatment of endometriosis via openalex
• Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
• Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
• Differences in characteristics among 1,000 women with endometriosis based on extent of disease via openalex
• Pre and post-operative medical therapy for endometriosis surgery via openalex
• Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain via openalex
• Subcutaneous Depot Medroxyprogesterone Acetate versus Leuprolide Acetate in the Treatment of Endometriosis-Associated Pain via openalex
• Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex
• The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex
• Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
• W2101417341 via openalex
• W1708141466 via openalex
• W6641669801 via openalex
• W6644136328 via openalex
• W6655025733 via openalex
• W6661593719 via openalex
• W6666024557 via openalex
• W6675305421 via openalex
• W2123134517 via openalex
• W6825204538 via openalex

Cited by (11)

• MODERN VIEWS ON THE ROLE OF PROGESTERONE IN THE PATHOGENESIS OF GENITAL ENDOMETRIOS 2023
• Peculiarities of the clinical course and pathomorphological picture of ovarian endometriosis and adenomyosis in reproductive aged women 2022
• Optimization of diagnostic studies in patients with adenomiosis and/or hyperplastic processes of endometrium 2021
• Characteristics of psycho-emotional manifestations and evaluation of the quality of life indicators in women with ovarian endometrioma combined with pelvic inflammatory diseases 2021
• PATHOGENETIC ROLE OF MACROPHAGE COLONY-STIMULATING FACTOR (CSF-1) IN PREDICTING ENDOMETRIOID DISEASE 2021
• DYNAMIC DETERMINATION OF MACROPHAGE COLONY–STIMULATING FACTOR (CSF–1) IN ENDOMETRIOID DISEASE IN MENSTRUAL BLOOD AT THE PREOPERATIVE STAGE AND AFTER THE FOLLOWING CONSERVATIVE TREATMENT 2021
• Anti-relapse therapy of endometriosis: possible variations 2021
• Chronic pelvic pain in women, stages and methods of diagnosis (Literature review) 2020
• Chronic abnormal uterine bleedings and quality of women’s life. How to significantly improve the result? 2020
• Features of climacteric syndrome in women with endometriosis 2018
• EFFECTIVENESS OF THE COMPLEX TREATMENT OF ENDOMETRIOSIS OF WOMEN’S SITUATIVE BODIES 2018

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00